Sara Faghihi-Kashani

Sara Faghihi-Kashani

National Institutes of Health - Bethesda / United States
Medical and Health Sciences / Neurology
AD Scientific Index ID: 4487586
person_outline Sara Faghihi-Kashani's MOST POPULAR ARTICLES
1-) Safety and efficacy of nanocurcumin as add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a pilot randomized clinical trialM Ahmadi, E Agah, S Nafissi, MR Jaafari, MH Harirchian, P Sarraf, ...Neurotherapeutics 15, 430-438, 2018852018
2-) An inverse association between serum vitamin D levels with the presence and severity of impaired nerve conduction velocity and large fiber peripheral neuropathy in diabetic …A Alamdari, R Mozafari, A Tafakhori, S Faghihi-Kashani, N Hafezi-Nejad, ...Neurological Sciences 36, 1121-1126, 2015852015
3-) A randomized, double-blind, placebo-controlled trial of infliximab in refractory polymyositis and dermatomyositisA Schiffenbauer, M Garg, C Castro, A Pokrovnichka, G Joe, J Shrader, ...Seminars in arthritis and rheumatism 47 (6), 858-864, 2018502018
4-) Defining anti-synthetase syndrome: a systematic literature reviewG Zanframundo, S Faghihi-Kashani, CA Scirè, F Bonella, TJ Corte, ...Clinical and experimental rheumatology 40 (2), 309, 2022622022
5-) Baseline high-sensitivity C-reactive protein predicts macrovascular and microvascular complications of type 2 diabetes: a population-based studyZ Aryan, A Ghajar, S Faghihi-Kashani, M Afarideh, M Nakhjavani, ...Annals of Nutrition and Metabolism 72 (4), 287-295, 2018492018